Modivcare Has Secured $75M In Incremental Financing, Backed By Stakeholders Across The Capital Structure, And Appointed Chad Shandler As Its Chief Transformation Officer. Existing Investor, Coliseum Capital Management, Has Also Committed $30M To...
Modivcare Has Secured $75M In Incremental Financing, Backed By Stakeholders Across The Capital Structure, And Appointed Chad Shandler As Its Chief Transformation Officer. Existing Investor, Coliseum Capital Management, Has Also Committed $30M To...
Modivcare已獲得7500萬美元的增量融資,得到資本結構各方利益相關者的支持,並任命Chad Shandler爲首席轉型官。現有投資者Coliseum Capital Management也承諾投資3000萬美元...
Modivcare Has Secured $75M In Incremental Financing, Backed By Stakeholders Across The Capital Structure, And Appointed Chad Shandler As Its Chief Transformation Officer. Existing Investor, Coliseum Capital Management, Has Also Committed $30M To Purchase New Second Lien Senior Notes Due 2029
Modivcare已經獲得7500萬美元的增量融資,得到了資本結構中各方股東的支持,並任命Chad Shandler爲首席轉型官。現有投資者Coliseum Capital Management還承諾投資3000萬美元購買到期於2029年的新第二留置權高級票據。
- $75 Million in Incremental Term Loan and $30 Million in New Second Lien Notes to Support Operational Improvements, Strategic Priorities and Covenant Relief
- Will Pursue Strategic Review of Assets with Key Company Advisors to Maximize Value
- Chief Transformation Officer and Board Additions Bolster Company Leadership
- Company Withdraws Previously Stated Revenue and Adjusted EBITDA Growth Guidance
- 7500萬美元的增量定期貸款和3000萬美元的新第二留置權票據以支持運營改善、戰略優先事項和契約寬限。
- 將與主要公司顧問共同進行資產的戰略評估,以最大化價值。
- 首席轉型官和董事會成員的增加增強了公司的領導力。
- 公司撤回了之前聲明的營業收入和調整後EBITDA增長指引。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。